Marimed (MRMD) Capital Expenditures (2014 - 2026)

Marimed (MRMD) has reported Capital Expenditures for 13 consecutive years, with $700000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 56.25% year-over-year to $700000.0 in Q2 2026; TTM through Jun 2026 was $2.3 million, a 65.05% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 78.21% from the prior year.
• Capital Expenditures was $700000.0 for Q2 2026 at Marimed, up from $373000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $5.4 million in Q4 2023 and troughed at -$101000.0 in Q4 2025.
• A 5-year average of $1.9 million and a median of $1.4 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 149.7% in 2023 and plunged 109.55% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $2.2 million in 2022, then jumped by 149.7% to $5.4 million in 2023, then slumped by 80.34% to $1.1 million in 2024, then sank by 109.55% to -$101000.0 in 2025, then surged by 793.07% to $700000.0 in 2026.
• The last three Capital Expenditures figures came in at $700000.0 (Q2 2026), $373000.0 (Q1 2026), and -$101000.0 (Q4 2025), per Business Quant data.